Literature DB >> 29747239

miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion.

Kuo-Hao Ho1,2,3,4, Cheng-Kuei Chang5, Peng-Hsu Chen2,3, Yu-Jia Wang6, Wei-Chiao Chang1,4,6,7,8, Ku-Chung Chen2,3.   

Abstract

Glioblastoma multiforme is the most common brain tumor in adults. Because of its highly invasive nature, it is not easy to treat, resulting in high mortality rates. Stromal interacting molecule 1 (Stim1) plays important roles in regulating store-operated Ca2+ entry, and controls invasion by cancer cells. However, the mechanisms and functions of Stim1 in glioma progression are still unclear. In this study, we investigated the effects of targeting Stim1 expression on glioma cell invasion. By analyzing profiles of glioblastoma multiforme patients from RNA-sequencing data in The Cancer Genome Atlas, higher expression levels of STIM1 were correlated with the poor survival. Furthermore, signaling pathways associated with tumor malignancy, including the epithelial-to-mesenchymal transition (EMT), were activated in patients with high STIM1 expression according to gene set enrichment analyses. Higher Stim1 levels were found in glioma cells compared to human astrocytes, and these higher levels enhanced glioma cell invasion. Xanthohumol (XN), a prenylated flavonoid extracted from the hop plant Humulus lupulus L. (Cannabaceae), significantly reduced cell invasion through inhibiting Stim1 expression. From an micro(mi)RNA array analysis, miR-4725-3p was up-regulated by XN treatment. Over-expression of miR-4725-3p inhibited glioma cell invasion via directly targeting the 3'-untranslated region of STIM1. The extracellular signal-regulated kinase/c-Fos pathway was also validated to participate in XN-up-regulated miR-4725-3p expression according to promoter and chromatin immunoprecipitation assays. These results emphasize that miR-4725-3p-inhibited STIM1 signaling is involved in XN-attenuated glioma cell invasion. These findings may provide insights into novel therapeutic strategies for future glioblastoma therapy and drug development. Open Data: Materials are available on https://cos.io/our-services/open-science-badges/ https://osf.io/93n6m/.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  glioblastoma multiforme; glioma invasion; miR-4725-3p; stromal interacting molecule 1; xanthohumol

Mesh:

Substances:

Year:  2018        PMID: 29747239     DOI: 10.1111/jnc.14459

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas.

Authors:  Kuo-Hao Ho; Peng-Hsu Chen; Chwen-Ming Shih; Yi-Ting Lee; Chia-Hsiung Cheng; Ann-Jeng Liu; Chin-Cheng Lee; Ku-Chung Chen
Journal:  Cell Mol Neurobiol       Date:  2020-10-06       Impact factor: 5.046

Review 2.  Potential role of microRNAs as biomarkers in human glioblastoma: a mini systematic review from 2015 to 2020.

Authors:  Manuela Rocha de Menezes; Maria Eduarda Azevêdo Acioli; Ana Carolina Lemos da Trindade; Suéllen Pedrosa da Silva; Raul Emídio de Lima; Vanessa Gabryelle da Silva Teixeira; Luydson Richardson Silva Vasconcelos
Journal:  Mol Biol Rep       Date:  2021-05-25       Impact factor: 2.316

3.  Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.

Authors:  Chisato Saeki; Juntaro Matsuzaki; Masahiko Kuroda; Koji Fujita; Makiko Ichikawa; Satoko Takizawa; Keiko Takano; Tsunekazu Oikawa; Yasuni Nakanuma; Masayuki Saruta; Takahiro Ochiya; Akihito Tsubota
Journal:  BMJ Open Gastroenterol       Date:  2022-04

Review 4.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

5.  CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.

Authors:  Bin Li; Jianhua Cheng; Hongyun Wang; Sida Zhao; Haibo Zhu; Chuzhong Li; Yazhuo Zhang; Peng Zhao
Journal:  J Transl Med       Date:  2019-10-04       Impact factor: 5.531

6.  Circular RNA profiles and the potential involvement of down-expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis.

Authors:  Pingjiao Chen; Changxing Li; Hongchang Huang; Liuping Liang; Jing Zhang; Qian Li; Qi Wang; Sanquan Zhang; Kang Zeng; Xibao Zhang; Jingyao Liang
Journal:  FEBS Open Bio       Date:  2021-03-11       Impact factor: 2.693

7.  Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination.

Authors:  Ayan Biswas; Dawei Zhou; Guillaume N Fiches; Zhenyu Wu; Xuefeng Liu; Qin Ma; Weiqiang Zhao; Jian Zhu; Netty G Santoso
Journal:  PLoS Pathog       Date:  2021-07-23       Impact factor: 7.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.